Table 1.
Demographic and clinical features of dermatomyositis and polymyositis patients
Groups | Number | Gender (male/female), n | Age (years) | Symptom duration (months) | MW (+/−), n | CK (2–200 U/L) | LDH (100–240 U/L) | EMG (+/−), n |
---|---|---|---|---|---|---|---|---|
DM | 12 | 6/6 | 38.92 ± 18.33 | 7.87 ± 6.48 | 12/0 | 2231.58 ± 1991.15 | 591.50 ± 392.46 | 9/3 |
PM | 10 | 4/6 | 37.50 ± 17.35 | 4.55 ± 3.91 | 10/0 | 2030.30 ± 1349.57 | 796.50 ± 572.89 | 9/1 |
DM: Dermatomyositis; PM: Polymyositis; MW: Muscle weakness; CK: Creatine kinase; LDH: Lactate dehydrogenase; EMG: Electromyography; +: Positive; −: Negative.